School Readiness Program for Sickle Cell Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program designed to prepare young children with sickle cell disease for school. The main goal is to determine if the adapted Kids in Transition to School Intervention is practical and well-received by children aged 3.5 to 6.5 years with sickle cell disease. Researchers will also compare the program's effectiveness to regular school resources and identify any challenges in its implementation. Participants include English-speaking children with sickle cell disease enrolled in a specific research program, along with a willing caregiver. As an unphased trial, this study allows participants to contribute to innovative educational support strategies for young children with sickle cell disease.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on a school readiness program, so it's unlikely that medication changes are required, but you should confirm with the trial coordinators.
What prior data suggests that this school readiness program is safe for children with sickle cell disease?
Research shows that the adapted Kids in Transition to School Intervention helps children with sickle cell disease prepare for school. An initial trial involved 24 children with sickle cell anemia in a similar school program. This program significantly improved their understanding of their condition without causing any negative effects.
While specific safety data for this exact program is unavailable, it focuses on educational support, suggesting it is likely safe. Similar educational programs have generally been safe, as they primarily involve learning activities and include caregivers. Any major safety issues would likely have been identified in earlier studies.12345Why are researchers excited about this trial?
Researchers are excited about the School Readiness Program for Sickle Cell Disease because it offers a novel approach to supporting children with this condition as they prepare for school. Unlike standard resources that simply provide information and books, this program involves interactive virtual classroom sessions where caregivers and children engage with educators and social workers. This personalized and immersive method aims to enhance school readiness skills, such as early math and reading, while also strengthening parent-child relationships. By focusing on these developmental areas, the program hopes to give children with sickle cell disease a better start in their educational journey.
What evidence suggests that the adapted Kids in Transition to School Intervention is effective for school readiness in children with sickle cell disease?
Research has shown that the Kids in Transition to School (KITS) Program could benefit children with sickle cell disease. In this trial, participants in the school readiness group will receive the adapted KITS Intervention. Previous studies have found that similar school programs can greatly improve children's understanding of their condition. Another study on children with developmental and behavior issues found that KITS helped them prepare for school by boosting early math and reading skills. These findings suggest that using KITS for children with sickle cell disease might enhance their school readiness by focusing on key learning and development areas. This targeted support may help children manage both their school and health challenges more effectively.12367
Who Is on the Research Team?
ANDREW Heitzer, PhD
Principal Investigator
St. Jude Children's Research Hospital
Are You a Good Fit for This Trial?
This trial is for preschool children aged 4-6 with sickle cell disease, or their caregivers. It aims to test a school readiness program specifically adapted for these children. Participants should be ready to engage in the study's activities and assessments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants attend virtual classroom program sessions for school readiness, including caregiver interviews and assessments
Follow-up
Participants are monitored for school readiness skills and caregiver satisfaction after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- The adapted Kids in Transition to School Intervention
Trial Overview
The trial is testing an adapted Kids in Transition to School Intervention against standard school resources provided to young children with sickle cell disease. The goal is to assess how feasible and acceptable this tailored intervention is.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
* Attend virtual classroom program sessions- If participants are in the school readiness group, the caregiver, will attend about 8 weeks of sessions virtually with a teacher or social worker and a caregiver of a child with sickle cell, for a total of 8 sessions. The sessions will be during the summer and done in a group. Each session will last about 1 ½ hours and will be video recorded. \> •Complete a caregiver interview-If participants are in the school readiness group, a member of the study team will interview you after the virtual classroom sessions are over. The interview will take about 15-20 minutes and will be audio recorded. Participants will be asked for suggestions and how satisfied you were with the program. * Complete assessments - Caregiver and participant will complete a set of assessments that evaluate school readiness skills (e.g., early math and reading), child behaviors, and parent-child relationships before and after the intervention.
Parents will be provided with information about preschool programs available in the community and age appropriate books for their children
Find a Clinic Near You
Who Is Running the Clinical Trial?
St. Jude Children's Research Hospital
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Published Research Related to This Trial
Citations
School Readiness Intervention for Preschool Children With ...
This study is being done to test a school readiness program for children with sickle cell disease (ages 3.5-6,5 years old). Primary Objective. Assess ...
Project Details - NIH RePORTER
This will be the first study to adapt and test an intervention approach fitted for patients with SCD, facilitating the development of targeted interventions ...
School Readiness Program for Sickle Cell Disease
A pilot trial involving 24 children with sickle cell anemia showed that a school intervention program (SIP) significantly improved disease knowledge among both ...
SKITS2: School Readiness Intervention for Sickle Cell ...
This study will test a school readiness program that St. Jude made for caregivers or parents of young children with sickle cell disease. This program is the ...
Efficacy Trial of the Kids in Transition to School (KITS) ...
This study focuses on children entering kindergarten with co-occurring developmental disabilities and behavior problems, a population especially likely to ...
Improving Health Care Transition for Young Patients With ...
In this quality improvement study of 458 pediatric patients with sickle cell disease, 5 hematology centers successfully implemented health care transition ...
Sickle Cell Trevor Thompson Transition Project (ST3P-UP) ...
Due to early diagnosis, innovative preventative therapies, and improved comprehensive care, over 95% of children with SCD will survive into adulthood [4]. While ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.